menu
    • menu
    [{"orgOrder":0,"company":"Adare Biome","sponsor":"Royal DSM","pharmaFlowCategory":"D","therapeuticArea":"Gastroenterology","country":"FRANCE","productType":"Large molecule","year":"2023","type":"Acquisition","leadProduct":"Lactobacillus LB","moa":"","graph1":"Gastroenterology","graph2":"Approved","graph3":"Adare Biome","amount2":0.29999999999999999,"highestDevelopmentShortName":"Approved","therapeuticAreaShortName":"Gastroenterology","amount2New":0.29999999999999999,"dosageForm":"Capsule","sponsorNew":"Adare Biome \/ Royal DSM","highestDevelopmentStatusID":"12","companyTruncated":"Adare Biome \/ Royal DSM"}]

    Find Clinical Drug Pipeline Developments & Deals by Adare Biome

    Menu

    Adare Biome

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Adare Biome

                            France arrow
                            Antibody Engineering
                            Not Confirmed

                            Adare Biome

                            France arrow
                            Antibody Engineering
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Lactobacillus LB

                            Therapeutic Area : Gastroenterology

                            Study Phase : Approved

                            Sponsor : Royal DSM

                            Deal Size : $302.8 million

                            Deal Type : Acquisition

                            DEALS_DEV arrow-down

                            DSM Agrees Terms To Acquire Postbiotics Pioneer Adare Biome

                            Details : The acquisition will facilitate DSM to anticipate in the rapidly extension of the availability of Lacteol (lactobacillus LB), an effective postbiotic treatment for diarrhea, engineered using adare's innovative microbiome technology platform, for people t...

                            Brand Name : Lacteol

                            Molecule Type : Large molecule

                            Upfront Cash : Undisclosed

                            April 19, 2023

                            Lead Product(s) : Lactobacillus LB

                            Therapeutic Area : Gastroenterology

                            Highest Development Status : Approved

                            Sponsor : Royal DSM

                            Deal Size : $302.8 million

                            Deal Type : Acquisition

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth